Stealth BioTherapeutics Profit Margin 2018-2021 | MITO
Current and historical gross margin, operating margin and net profit margin for Stealth BioTherapeutics (MITO) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Stealth BioTherapeutics net profit margin as of June 30, 2021 is 0%.
|Stealth BioTherapeutics Annual Profit Margins
|Stealth BioTherapeutics Quarterly Profit Margins
||Medical - Biomedical and Genetics
Stealth BioTherapeutics Corp is a biopharmaceutical company. It is engaged in developing therapies to treat the mitochondrial dysfunction associated with genetic mitochondrial diseases and many common age-related diseases. The company's product pipeline includes Elamipretide, SBT-20 and SBT-272 which are in clinical stage. Stealth BioTherapeutics Corp is based in Newton, Massachusetts.